Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50,013,453
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
409,378
-
Shares change
-
-20,461
-
Total reported value, excl. options
-
$686,000
-
Value change
-
+$3,717
-
Number of buys
-
5
-
Number of sells
-
4
-
Price
-
$1.69
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q3 2022
As of 30 Sep 2022 NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 409,378 shares of stock of the company.
Largest 9 holders included GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, DRIVE WEALTH MANAGEMENT, LLC, MAI Capital Management, STATE STREET CORP, JANE STREET GROUP, LLC, Newport Capital Group, LLC, NORTHERN TRUST CORP, and Tower Research Capital LLC (TRC).
This table shows 9 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.